RON LOOMIS: Open Payments
NPI 1740054469 · SUN CITY, AZ. Company-reported industry payments from CMS Open Payments. A payment does not imply wrongdoing.
See the full provider profile for registry, prescribing and billing details.
Industry payments (Sunshine Act)
Source: CMS Open Payments general payments. Payments from drug and device companies are reported by the companies; they do not imply wrongdoing and are separate from Medicare billing.
$2,696 in 94 payments from 20 companies in 2025. Trend: 2023 $117 · 2024 $1,712 · 2025 $2,696
Food & beverage: $2,696
| Company | Payments | Amount |
|---|---|---|
| AstraZeneca Pharmaceuticals LP | 14 | $577 |
| GlaxoSmithKline, LLC. | 12 | $392 |
| Amgen Inc. | 12 | $356 |
| Sumitomo Pharma America, Inc. | 9 | $242 |
| Edwards Lifesciences Corporation | 3 | $227 |
| Lilly USA, LLC | 13 | $188 |
| Astellas Pharma US Inc | 5 | $134 |
| Corcept Therapeutics | 3 | $80 |
| Salix Pharmaceuticals, a division of Bausch Health US, LLC | 5 | $75 |
| Medtronic, Inc. | 1 | $64 |
Products named: AIRSUPRA, GEMTESA, SAPIEN 3 Ultra RESILIA, EVENITY, BREZTRI, SHINGRIX, Veozah, AREXVY.
Industry payments across AZ — which companies pay providers there.
